Post navigation Alphyn Closes $25M Oversubscribed Series B Financing Round to Advance Dermatology PipelineSobi Receives Positive CHMP Opinion for Aspaveli® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN